Researchers have identified an epigenetic transcription regulator that appears to influence the aggressiveness of pancreatic cancer cells
Oncology is the most advanced area in genomics right now. The field is setting the standard for other indications to follow and improve upon.
We’ve caught up with Mike before his participation in the panel: ‘Can we fully integrate genomics into the NHS within 5 years?’ at the Festival of Genomics 2018.
Applying an FDA-approved nutrition source called Intralipid before nano-drug chemotherapy can reduce the amount of the toxic drugs that settle in the body.
Companion diagnostic test for multiple cancers wins approval from both the FDA and CMS.
Harvard’s CRISPR pioneer, Chad Cowan has signed on to handle the preclinical work for new drugs slated to join the pipeline at a well-financed Mustang Bio.
Researchers have refined and, for the first time, run in vivo tests of a method that may allow nanotube-based probes to locate specific tumours in the body.
Scientists have figured out how invasive cells deploy a trick to break through tissues, this may help explain how cancer spreads to other parts of the body.
Workarounds show robust mechanisms in place to keep surviving despite mutations.
GlaxoSmith Kline (GSK) has welcomed the news that two of its drug regimen to treat HIV have won US approval, with its Juluca treatment.
A genome-wide association study has identified 4 novel SNPs that may be able to act as prognostic tools for early-onset breast cancer in young women
Molecular ‘detector’ recognizes most frequent cancer-mutation in cells and initiates to kill them.